Finance

Beta
Lists
2228:HKG
XtalPi Holdings Ltd
HK$8.24
-4.19%
(-0.36) 1D
May 29, 4:08:24 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2228...
Open
HK$8.75
High
HK$8.78
Low
HK$8.23
Mkt. cap
35.46B
Avg. vol.
58.47M
Volume
74.05M
P/E ratio
248.12
52-wk high
HK$15.12
52-wk low
HK$4.34
EPS
HK$0.03
Shares outstanding
4.30B
No. of employees
1K
Open
HK$8.75
High
HK$8.78
Low
HK$8.23
Mkt. cap
35.46B
Avg. vol.
58.47M
Volume
74.05M
P/E ratio
248.12
52-wk high
HK$15.12
52-wk low
HK$4.34
EPS
HK$0.03
Shares outstanding
4.30B
No. of employees
1K
News stories
From sources across the web
Profile
XtalPi Holdings Limited is a publicly listed Chinese biotechnology company that engages in research and development for early-stage drug discovery and material science through methods backed by artificial intelligence. Wikipedia
About XtalPi Holdings Ltd
CEO-
Employees1.2K
Founded2015
Headquarters-
SectorHealth care
Websitextalpi.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
258.54M
258.54M
142.77M
142.77M
Cost of goods sold
40.98M
40.98M
80.74M
80.74M
Cost of revenue
40.98M
40.98M
80.74M
80.74M
Research and development expenses
110.76M
110.76M
173.83M
173.83M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
120.34M
120.34M
125.19M
125.19M
Operating expense
220.32M
220.32M
290.26M
290.26M
Total operating expenses
261.30M
261.30M
371.00M
371.00M
Operating income
-2.76M
-2.76M
-228.22M
-228.22M
Other non operating income
-
-
-
-
EBT including unusual items
37.80M
37.80M
29.87M
29.87M
EBT excluding unusual items
21.76M
21.76M
-207.72M
-207.72M
Income tax expense
-
-
389.50K
389.50K
Effective tax rate
-
-
1.30%
1.30%
Other operating expenses
-10.78M
-10.78M
-8.76M
-8.76M
Net income
41.40M
41.40M
20.48M
20.48M
Net profit margin
16.01%
16.01%
14.34%
14.34%
Earnings per share
-
-
-
-
Interest and investment income
25.94M
25.94M
32.93M
32.93M
Interest expense
-1.83M
-1.83M
-2.86M
-2.86M
Net interest expenses
24.11M
24.11M
30.07M
30.07M
Depreciation and amortization charges
-
-
-
-
EBITDA
18.20M
18.20M
-209.63M
-209.63M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer